Infuse lawsuits pile up for Medtronic | Legal News

Infuse

Personal injury lawsuits over its controversial Infuse bone-growth protein are beginning to pile up for Medtronic Inc. (NYSE:MDT), after the Spine Journal revealed serious concerns about the device’s safety this summer.

In June, the journal took the unprecedented step of devoting an entire issue to the Infuse controversy. Its investigation found problems with 13 studies by MDT-sponsored physicians, all of which downplayed or omitted the rates of adverse events associated with the protein, known as recombinant human bone morphogenetic protein-2.

Although the furor ignited by the study eventually died down on Wall Street (where analysts warned of a possible 3-cent-per-share dip in overall profits), Medtronic and Infuse are under intense scrutiny elsewhere. The U.S. Justice Dept. and the U.S. Senate are each conducting probes into the bone morphogenetic compound and its Fridley, Minn.-based maker’s marketing practices.

Sign up to get our free newsletters delivered straight to your inbox

Now Jennifer English is the latest in what’s likely to become a long line of plaintiffs to file personal injury suits against the Fridley, Minn.-based medical device colossus. The of Lake Worth, Fla., woman was implanted with an Infuse device in August 2007, according to court documents. But the rhBMP-2 embedded in the device allegedly caused ectopic bone growth that compressed nerves and required two revision surgeries to remove the out-of-control bone growth.

“I trusted Medtronic with my life,” English said in prepared remarks. “It is disappointing to find out Medtronic is not looking out for the best interests of the patient, but for own its financial interests.”
English’s complaint accuses Medtronic of fraudulently misrepresenting the device’s risks and of improperly promoting and marketing Infuse for off-label uses, according to documents filed with the U.S. District Court for Southern Florida.

Medtronic spokesman Steve Cragle told MassDevice in July that the company hasn’t “heard any feedback from our customers that they are reducing their expected use.” Infuse, Cragle told us, is a “physician-pull product,” meaning that Medtronic reps don’t actively promote it and aren’t compensated for any Infuse sales.

“So it’s up to the physician to determine when to use our product,” Cragle wrote in an email.

Medtronic pulls down between $700 million and $750 million from Infuse alone, analysts estimate.

Read more medical device legal news from MassDevice.com

Beckman Coulter settles class-action shareholders’ suit for $5.5 million

Beckman Coulter Inc. agreed to pony up $5.5 million to settle a class-action shareholders’ lawsuit accusing it of failing to disclose regulatory and quality issues in time to prevent damage to its share price.

The Brea, Calif.-based company, which was acquired by Danaher Corp. (NYSE:DHR) for $6.8 billion in February, asked Judge Josephine Tucker of the U.S. District Court for Central California to approve the settlement agreement between Beckman and the plaintiffs, led by the Arkansas Teacher Retirement System and the Iron Workers District Counsel of New England Pension Fund.

The securities fraud class action alleged that Beckman and its management made “material misstatements and omissions regarding product quality, safety, United States Food and Drug Administration regulatory compliance and the company’s troponin test kits, as well as likely customer retention, recurring revenue, business prospects, and earnings forecasts and guidance,” according to court documents.

“Lead plaintiff alleges that defendants failed to make earlier disclosure of alleged non-compliance with FDA pre-market notification requirements concerning modifications made to the company’s troponin tests, and failed to make earlier disclosure of the effects of noncompliance on the company’s operations, products and prospects,” according to the documents.

If approved by Tucker, would see the plaintiffs receive $ 5 million in cash; Beckamn would pay another $500,000 “for the expenses incurred in providing notice to the class and administering the settlement,” according to the documents.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Comments

  1. says

    I simply want to say I am beginner to blogging and site-building and honestly enjoyed you’re web-site. Probably I’m likely to bookmark your website . You certainly come with great articles and reviews. Appreciate it for revealing your website page.

  2. says

    Hello Web Admin, I noticed that your On-Page SEO is is missing a few factors, for one you do not use all three H tags in your post, also I notice that you are not using bold or italics properly in your SEO optimization. On-Page SEO means more now than ever since the new Google update: Panda. No longer are backlinks and simply pinging or sending out a RSS feed the key to getting Google PageRank or Alexa Rankings, You now NEED On-Page SEO. So what is good On-Page SEO?First your keyword must appear in the title.Then it must appear in the URL.You have to optimize your keyword and make sure that it has a nice keyword density of 3-5% in your article with relevant LSI (Latent Semantic Indexing). Then you should spread all H1,H2,H3 tags in your article.Your Keyword should appear in your first paragraph and in the last sentence of the page. You should have relevant usage of Bold and italics of your keyword.There should be one internal link to a page on your blog and you should have one image with an alt tag that has your keyword….wait there’s even more Now what if i told you there was a simple WordPress plugin that does all the On-Page SEO, and automatically for you? That’s right AUTOMATICALLY, just watch this 4minute video for more information at. Seo Plugin

Trackbacks

  1. Obat Herbal Tanpa Efek Samping

    bagaimana cara menyembuhkan penyakit kutil kelamin dengan cepat? kutil kelamin pada dasarnya dapat disembuhkan tanpa operasi yaitu menggunakan obat kutil kelamin kelamin de nature indonesia yang terdiri dari kapsul bersih darah, pipeca, gang jie, gho s…

  2. Obat Herbal de Nature

    Apakah bapak membutuhkan obat herbal de Nature Indonesia silahkan dapat hubungi customer service kita secara langsung lewat SMS ataupun Telepon. Kami selalu online 24 jam utk melayani pembelian obat herbal de Nature.

  3. Hi, nice to see your website

    Apakah kalian membutuhkan obat herbal de Nature Indonesia silahkan dapat hubungi customer service kita secara langsung lewat SMS ataupun Telepon. Kami selalu online 24 jam utk melayani pembelian obat herbal de Nature.

  4. My name is Eko Priyanto

    Apakah kamu membutuhkan obat herbal de Nature Indonesia silahkan dapat hubungi customer service kita secara langsung melalui SMS ataupun Telepon. Kami selalu online 24 jam utk melayani pembelian obat herbal de Nature.

Leave a Reply